Skip to main content
. 2017 Apr 1;11(4):NC01–NC06. doi: 10.7860/JCDR/2017/24496.9686

[Table/Fig-3]:

Ophthalmic appraisals observed in the study groups.

Cases* Controls
Retinopathy- Right No apparent retinopathy 2 (2.1) 26 (100.0)
Mild NPR 26 (26.8) 0 (0)
Moderate NPR 25 (25.8) 0 (0)
Severe NPR 27 (27.8) 0 (0)
Very severe NPR 8 (8.2) 0 (0)
PDR 9 (9.3) 0 (0)
Retinopathy- Left No apparent retinopathy 1 (1.0) 26 (100.0)
Mild NPR 33 (34.0) 0 (0)
Moderate NPR 35 (36.1) 0 (0)
Severe NPR 16 (16.5) 0 (0)
Very severe NPR 2 (2.1) 0 (0)
PDR 10 (10.3) 0 (0)
History of screening for DR Yes 40 (41.7) 12 (46.2)
No 56 (58.3) 14 (53.8)
Fundus Fluorescein Angiography Yes 11 (11.5) 0 (0)
No 85 (88.5) 26 (100.0)
Optical Coherence Tomography Yes 8 (8.3) 0 (0)
No 88 (91.7) 26 (100.0)
Prior laser Yes 9 (9.4) 0 (0)
No 87 (90.6) 26 (100.0)
Colour vision Present 77 (89.5) 26 (100.0)
Absent 9 (10.5) 0 (0)
Knowledge of blurring of vision during hypoglycemia Yes 37 (45.7) 11 (42.3)
No 44 (54.3) 15 (57.7)
Diminution of vision Painful 0 (0) 0 (0)
Painless- Sudden 1 (1.1) 0 (0)
Painless- Gradual 93 (98.9) 26 (100.0)
High risk PDR Yes 6 (6.6) 0 (0)
No 85 (93.4) 26 (100.0)
With clinically significant macular edema Yes 36 (38.7) 0 (0)
No 57 (61.3) 26 (100.0)

* = Of the DR subjects, some volunteers did not answer some questions considered in [Table/Fig-1,2,3 and 4] and therefore do not add up to 97. Only the answered choices were considered for the analysis